Prevalence of KRAS, NRAS and BRAF mutations in patients with colorectal... | Download Scientific Diagram
IJMS | Free Full-Text | Gene Therapy Targeting p53 and KRAS for Colorectal Cancer Treatment: A Myth or the Way Forward?
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
:max_bytes(150000):strip_icc()/kras-g12c-mutation-in-nsclc-4843957-v3-456bf340786c481b857d044b6a8cb307-b4828f2507074811b94472745e488299.png "KRAS Positive Lung Cancer: Testing and Management")
KRAS Positive Lung Cancer: Testing and Management
TAK1 Inhibition Promotes Apoptosis in KRAS-Dependent Colon Cancers: Cell
Metformin selectively inhibits metastatic colorectal cancer with the KRAS mutation by intracellular accumulation through silencing MATE1 | PNAS
![Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/9149/1/fig-2-2x.jpg "Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis [PeerJ]")
Prognostic value of KRAS mutation status in colorectal cancer patients: a population-based competing risk analysis [PeerJ]
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Can KRAS Positive Colorectal and Lung Cancer Finally be Targeted? - CancerConnect
KRAS mutation: from undruggable to druggable in cancer | Signal Transduction and Targeted Therapy
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C | NEJM
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
The current understanding on the impact of KRAS on colorectal cancer - ScienceDirect
KRAS Biomarker | Colorectal Cancer Alliance
Associations between nutritional factors and KRAS mutations in colorectal cancer: a systematic review | BMC Cancer | Full Text
The Prognostic Impact of KRAS G12C Mutation in Patients with Metastatic Colorectal Cancer: A Multicenter Retrospective Observational Study - Chida - 2021 - The Oncologist - Wiley Online Library
Frontiers | New Horizons in KRAS-Mutant Lung Cancer: Dawn After Darkness
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer | Molecular Cancer | Full Text
KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin‑ or irinotecan‑based treatment
The mutation distribution of KRAS/NRAS/BRAF in (A) colon cancer, (B)... | Download Scientific Diagram
Impact of KRAS Mutations on Management of Colorectal Carcinoma
Frontiers | Targeting KRAS: The Elephant in the Room of Epithelial Cancers
